CN110256591B - Cordyceps sinensis polysaccharide extract and preparation method and application thereof - Google Patents
Cordyceps sinensis polysaccharide extract and preparation method and application thereof Download PDFInfo
- Publication number
- CN110256591B CN110256591B CN201910546545.5A CN201910546545A CN110256591B CN 110256591 B CN110256591 B CN 110256591B CN 201910546545 A CN201910546545 A CN 201910546545A CN 110256591 B CN110256591 B CN 110256591B
- Authority
- CN
- China
- Prior art keywords
- extract
- water
- polysaccharide
- cordyceps sinensis
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 135
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 129
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 129
- 239000000284 extract Substances 0.000 title claims abstract description 81
- 241001248610 Ophiocordyceps sinensis Species 0.000 title claims abstract description 50
- 238000000605 extraction Methods 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 80
- 239000011347 resin Substances 0.000 claims abstract description 35
- 229920005989 resin Polymers 0.000 claims abstract description 35
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 24
- 238000001556 precipitation Methods 0.000 claims abstract description 19
- 230000003544 deproteinization Effects 0.000 claims abstract description 16
- 239000003814 drug Substances 0.000 claims abstract description 11
- 230000000259 anti-tumor effect Effects 0.000 claims abstract description 10
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 89
- 239000000243 solution Substances 0.000 claims description 66
- 238000000502 dialysis Methods 0.000 claims description 23
- 239000007788 liquid Substances 0.000 claims description 23
- 239000006286 aqueous extract Substances 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 108090000623 proteins and genes Proteins 0.000 claims description 11
- 102000004169 proteins and genes Human genes 0.000 claims description 11
- 238000010992 reflux Methods 0.000 claims description 11
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 235000000346 sugar Nutrition 0.000 claims description 9
- 230000014759 maintenance of location Effects 0.000 claims description 7
- 239000003480 eluent Substances 0.000 claims description 6
- 239000012074 organic phase Substances 0.000 claims description 6
- 206010006187 Breast cancer Diseases 0.000 claims description 5
- 208000026310 Breast neoplasm Diseases 0.000 claims description 5
- 238000005119 centrifugation Methods 0.000 claims description 5
- 206010025323 Lymphomas Diseases 0.000 claims description 4
- 206010009944 Colon cancer Diseases 0.000 claims description 3
- 238000004458 analytical method Methods 0.000 claims description 3
- 238000005227 gel permeation chromatography Methods 0.000 claims description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 2
- 229960004756 ethanol Drugs 0.000 claims 5
- 150000008163 sugars Chemical class 0.000 claims 2
- 229960000935 dehydrated alcohol Drugs 0.000 claims 1
- 201000005787 hematologic cancer Diseases 0.000 claims 1
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000035614 depigmentation Effects 0.000 abstract description 2
- 239000010410 layer Substances 0.000 description 27
- 235000019441 ethanol Nutrition 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 16
- 241000190633 Cordyceps Species 0.000 description 10
- 239000012071 phase Substances 0.000 description 10
- 208000032839 leukemia Diseases 0.000 description 6
- 238000001179 sorption measurement Methods 0.000 description 6
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000012869 ethanol precipitation Methods 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 3
- 239000005695 Ammonium acetate Substances 0.000 description 3
- 229940043376 ammonium acetate Drugs 0.000 description 3
- 235000019257 ammonium acetate Nutrition 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 230000002538 fungal effect Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 201000001441 melanoma Diseases 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 239000003729 cation exchange resin Substances 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 238000010606 normalization Methods 0.000 description 2
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000007670 refining Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 241000235349 Ascomycota Species 0.000 description 1
- 241000221955 Chaetomium Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 241000244206 Nematoda Species 0.000 description 1
- 229930189092 Notoginsenoside Natural products 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 241001326533 Sordariomycetes Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N acrylic acid methyl ester Natural products COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000007098 aminolysis reaction Methods 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 239000003957 anion exchange resin Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical group 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000003712 decolorant Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000004185 ester group Chemical group 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 238000007667 floating Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 229940089161 ginsenoside Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000010842 industrial wastewater Substances 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010829 isocratic elution Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000002777 nucleoside Substances 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 238000000967 suction filtration Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000004065 wastewater treatment Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Materials Engineering (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Sustainable Development (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
本发明属于中药材提取领域，提供了一种冬虫夏草多糖提取物及其制备方法和应用，具体地，提供了一种冬虫夏草多糖提取物的制备方法，及经这样的制备方法制备的具有较高抗肿瘤活性的冬虫夏草多糖提取物，还提供了这样的冬虫夏草多糖提取物在制备用于抗肿瘤的药物中的应用。所述制备方法包括用乙醇醇沉粗多糖，用Sevag试剂进行脱蛋白，以及用大孔树脂脱色素的步骤，从而获得经脱蛋白和脱色素的冬虫夏草多糖提取物。
The invention belongs to the field of extraction of Chinese medicinal materials, and provides a Cordyceps sinensis polysaccharide extract and a preparation method and application thereof, in particular, provides a preparation method of the Cordyceps sinensis polysaccharide extract, and a polysaccharide extract prepared by such a preparation method has a high resistance to The tumor-active cordyceps sinensis polysaccharide extract also provides the application of such cordyceps sinensis polysaccharide extract in preparing medicines for anti-tumor. The preparation method includes the steps of alcohol precipitation of crude polysaccharide with ethanol, deproteinization with Sevag reagent, and depigmentation with macroporous resin, thereby obtaining a deproteinized and depigmented Cordyceps sinensis polysaccharide extract.
Description
Technical Field
The invention belongs to the field of extraction of traditional Chinese medicinal materials, relates to preparation of a polysaccharide extract of the traditional Chinese medicinal materials, and particularly relates to preparation and application of a polysaccharide extract of cordyceps sinensis.
Background
The cordyceps sinensis is a traditional and rare Chinese medicinal material in China, belongs to ascomyceta (Ascomycota) Chaetomium (Sordariomycetes), Hypocrea (Hypocrea) and nematoda (Ophiocery picitaceae), has a long medicinal history in China, and has the effects of tonifying lung and kidney, and stopping bleeding and reducing phlegm. Modern chemical and pharmacological research shows that the cordyceps sinensis contains various chemical components such as nucleoside, sugar, sterol, protein and the like, and has pharmacological effects of regulating immunity, relieving lung diseases, resisting tumors and the like.
At the early stage, the anti-tumor effect of Cordyceps sinensis is reported, for example, the inhibition rate of Cordyceps sinensis polysaccharide to mouse sarcoma S180 is 28% -33% when the concentration of Cordyceps sinensis polysaccharide is 100mg/10g, as described in the literature pharmacological action of Cordyceps sinensis polysaccharide (Chinese herbal medicine, 1985, 16(7): 18-23); the literature, "Effect of cordyceps sinensis on the promotion and differentiation of human leukemia U937 cells" [ life sciences,60(25):2349-2359] reports that the inhibition rate of cordyceps sinensis polysaccharide on human leukemia U937cells is 78% -83% at a concentration of 10 μ g/mL; some researches have been made on the antitumor activity of the crude extract of Cordyceps sinensis, for example, patent "an antitumor activity of fresh Cordyceps sinensis extract and its preparation method and application" (application No.: CN201611221881.5) discloses that the suppression rate of breast cancer cell MDA-MB-453 by fresh Cordyceps sinensis water extract at a concentration of 0.25-3 mg/mL is 39.0-86.7%.
The polysaccharide is widely present in animal cell membranes, plant and microbial cell walls, is a natural high molecular compound, is separated from fruiting bodies, mycelia or fermentation liquor of fungi, and has various biological activities of resisting viruses, resisting coagulation, resisting tumors, regulating immunity, reducing blood fat and the like. However, the extraction of the fungal polysaccharide has many problems due to the influence of protein and pigment removal in the extraction process of the fungal polysaccharide, and the characteristics of poor extraction purity and low stability, such as high polarity, difficult volatilization, thermal instability, high molecular weight and the like of the polysaccharide, such that the extraction of the fungal polysaccharide has many problems. At present, there is a great demand for cordyceps sinensis polysaccharide extracts having high antitumor activity.
Disclosure of Invention
The invention provides a preparation method of a cordyceps sinensis polysaccharide extract, provides the cordyceps sinensis polysaccharide extract with high anti-tumor activity prepared by the preparation method, and also provides application of the cordyceps sinensis polysaccharide extract in preparing anti-tumor medicines. The cordyceps polysaccharide extract is a polysaccharide extract which is deproteinized and decolored, and has good inhibitory activity on cancer cells, particularly on leukemia K-562 cells.
In a first aspect, the present invention provides a method for preparing a cordyceps sinensis polysaccharide extract, comprising the following steps:
(1) extracting Cordyceps with water under heating to obtain extract, and eluting with water to obtain water extract;
(2) adding ethanol into the water extract obtained in the step (1) for ethanol precipitation to obtain ethanol precipitation crude polysaccharide;
(3) dissolving the alcohol-precipitated crude polysaccharide obtained in the step (2) in water to obtain a crude polysaccharide solution, and then adding a sevag reagent according to the volume ratio of the crude polysaccharide solution to the sevag reagent of 3:1-5:1 for deproteinization to obtain deproteinized crude polysaccharide; and
(4) and (4) decoloring the deproteinized crude polysaccharide obtained in the step (3) by using macroporous resin.
Preferably, the method comprises the steps of:
(1) extracting Cordyceps with water at 80-100 deg.C under heating to obtain extract, and eluting with water to obtain water extract;
(2) adding ethanol into the water extract obtained in the step (1) for ethanol precipitation to obtain ethanol precipitation crude polysaccharide;
(3) dissolving the alcohol-precipitated crude polysaccharide obtained in the step (2) in water according to a material-liquid ratio of 1: 18-1: 22(g/mL) to obtain a crude polysaccharide solution, and then adding a sevag reagent according to a volume ratio of the crude polysaccharide solution to the sevag reagent of 3:1-5:1 to perform deproteinization to obtain deproteinized crude polysaccharide; and
(4) and (4) decoloring the deproteinized crude polysaccharide obtained in the step (3) by using macroporous resin.
Preferably, in the step (1), the heating extraction is reflux extraction, the material-liquid ratio of the heating extraction is 1:8-1:12(kg/L), and the extraction is carried out for 2-4 hours; preferably, the residue after heating extraction is continuously subjected to reflux extraction for 2-3 times according to the material-liquid ratio of 1:8-1:12(kg/L), each time for 2-4h, and the extracting solutions are combined.
Preferably, after the extract is obtained in step (1), the extract is adsorbed on a macroporous resin and eluted with water to obtain an aqueous extract.
Preferably, the aqueous extract in the step (2) is an aqueous solution of the aqueous extract with a material-to-liquid ratio of 1:3-1:6 (g/mL); in the step (2), the ethanol is absolute ethanol, and the volume ratio of the absolute ethanol to the aqueous solution of the water extract is 3:1-5: 1.
Preferably, the aqueous extract in the step (2) is an aqueous solution of the aqueous extract with a material-to-liquid ratio of 1:5 (g/mL); in the step (2), the ethanol is absolute ethanol, and the volume ratio of the absolute ethanol to the aqueous solution of the water extract is 4: 1.
Preferably, the alcohol precipitation in the step (2) is carried out at room temperature, and the alcohol precipitation time is more than 8 hours.
Preferably, the volume ratio of the crude polysaccharide solution to the sevag reagent in the step (3) is 4: 1.
Preferably, step (3) is repeated before step (4) until the centrifuged aqueous layer and the organic phase have no protein layer, and the deproteinized aqueous layer solution is obtained as the deproteinized crude polysaccharide, specifically, the following steps are repeated: adding a sevag reagent into the crude polysaccharide solution, centrifuging after fully shaking, taking a water phase layer, and repeatedly performing deproteinization operation until no protein layer exists between the centrifuged water phase layer and the organic phase layer to obtain a deproteinized water phase layer solution, namely the deproteinized crude polysaccharide; preferably, the deproteinized aqueous phase layer solution is further added with 4-5 times volume of absolute ethyl alcohol, and after alcohol precipitation, the crude polysaccharide after deproteinization is obtained by centrifugation.
Preferably, in the step (3), 4 to 5 times volume of absolute ethanol is slowly added to the deproteinized aqueous phase solution while stirring, and the mixture is precipitated with ethanol at 4 ℃ overnight and then centrifuged at 5000rpm for 10 minutes to obtain deproteinized crude polysaccharide (DPCSP).
Preferably, in the step (4), the macroporous resin is AB-8 macroporous resin, D-941 macroporous resin, D-113 macroporous resin or D-101 macroporous resin; more preferably, in said step (5), the macroporous resin is AB-8 macroporous resin.
Preferably, the step (4) is: adding the deproteinized crude polysaccharide obtained in the step (3) to an AB-8 macroporous resin column, eluting with water to obtain an eluent, concentrating, and dialyzing with 2kDa dialysis bag pure water to obtain a solution in a dialysis bag after dialysis; preferably, the solution in the dialysis bag is further freeze-dried to obtain crude de-pigmented polysaccharide (DCCSP).
Preferably, the invention provides a preparation method of the cordyceps sinensis polysaccharide extract, which comprises the following steps:
(1) extracting pulverized Cordyceps with water under reflux for 2-4 hr at a ratio of material to liquid of 1:8-1:12 (kg/L); preferably, the residue after reflux extraction is continuously subjected to reflux extraction for 2-3 times according to the material-liquid ratio of 1:8-1:12(kg/L), the extraction time is 2-4h each time, and the extracting solutions are combined;
concentrating the extractive solution to obtain extract, adsorbing with HP-20 macroporous resin, eluting with water, concentrating the eluate, and freeze drying to obtain water extract;
(2) dissolving the water extract obtained in the step (1) in water according to a material-to-liquid ratio of 1:3-1:6(g/mL) to obtain a water solution of the water extract; then adding absolute ethyl alcohol for alcohol precipitation to obtain alcohol precipitation crude polysaccharide, wherein the volume ratio of the absolute ethyl alcohol to the aqueous solution of the water extract is 3:1-5: 1;
(3) adding the alcohol-precipitated crude polysaccharide obtained in the step (2) into water according to a material-liquid ratio of 1: 18-1: 22(g/mL) to obtain a crude polysaccharide solution, and then adding a sevag reagent according to a volume ratio of the crude polysaccharide solution to the sevag reagent of 4:1 to perform deproteinization, wherein the specific operation is as follows: adding a sevag reagent into the crude polysaccharide solution, centrifuging after fully shaking, taking a water phase layer, and repeatedly performing deproteinization operation until no protein layer exists between the centrifuged water phase layer and the organic phase layer to obtain a deproteinized water phase layer solution, namely the deproteinized crude polysaccharide; preferably, the deproteinized aqueous phase layer solution is further added with 4-5 times volume of absolute ethyl alcohol, and the crude polysaccharide after deproteinization is obtained by alcohol precipitation and centrifugation; and
(4) adding the deproteinized crude polysaccharide obtained in the step (3) to an AB-8 macroporous resin column, eluting with water to obtain an eluent, concentrating, and dialyzing with 2kDa dialysis bag pure water to obtain a dialyzed solution in a dialysis bag; preferably, the solution in the dialysis bag is further freeze-dried to obtain crude de-pigmented polysaccharide (DCCSP).
Preferably, the invention provides a preparation method of the cordyceps sinensis polysaccharide extract, which comprises the following steps:
(1) extracting pulverized Cordyceps with water under reflux for 2-4 hr at a ratio of 1:8-1:12(kg/L), extracting the residue under reflux for 2-3 times at a ratio of 1:8-1:12(kg/L), each time for 2-4 hr, and mixing extractive solutions;
concentrating the extractive solution to obtain extract, adsorbing with HP-20 macroporous resin, eluting with water, concentrating the eluate, and freeze drying to obtain water extract;
(2) dissolving the water extract obtained in the step (1) in water according to the material-liquid ratio of 1:5(g/mL) to obtain a water extract aqueous solution; then adding absolute ethyl alcohol for alcohol precipitation to obtain alcohol precipitation crude polysaccharide, wherein the volume ratio of the absolute ethyl alcohol to the aqueous solution of the water extract is 4: 1;
(3) adding the alcohol precipitated crude polysaccharide obtained in the step (2) into water according to the material-liquid ratio of 1:20(g/mL) to obtain a crude polysaccharide solution, and then adding a sevag reagent according to the volume ratio of the crude polysaccharide solution to the sevag reagent of 4:1 to remove protein, wherein the specific operation is as follows: adding sevag reagent into the crude polysaccharide solution, fully oscillating, centrifuging, taking a water phase layer, and repeatedly performing deproteinization operation until the centrifuged water phase layer and the organic phase layer have no protein layer to obtain a deproteinized water phase layer solution; adding 4-5 times volume of anhydrous ethanol into the deproteinized aqueous phase layer solution, precipitating with ethanol at 4 deg.C, and centrifuging at 5000rpm for 10min to obtain deproteinized crude polysaccharide; and
(4) and (3) adding the deproteinized crude polysaccharide obtained in the step (3) to an AB-8 macroporous resin column, eluting with water to obtain an eluent, concentrating, dialyzing with 2kDa dialysis bag pure water to obtain a solution in a dialysis bag, and further freezing and drying the solution in the dialysis bag to obtain crude decolorant polysaccharide (DCCSP).
In a second aspect, the invention provides a cordyceps sinensis polysaccharide extract prepared by the method of the invention.
In a third aspect, the invention provides a cordyceps sinensis polysaccharide extract, which has a total sugar content of 85-90% and comprises low molecular weight polysaccharides and high molecular weight polysaccharides, wherein the low molecular weight polysaccharides are polysaccharides with an average molecular weight of 6.5-7.0 kDa and account for about 75% of the total sugar by mass, and the high molecular weight polysaccharides have an average molecular weight of more than 670kDa and account for about 25% of the total sugar by mass.
Preferably, the average molecular weight of the low molecular weight polysaccharides in the cordyceps sinensis polysaccharide extract is 6.86 kDa.
Preferably, the cordyceps sinensis polysaccharide extract shows three peaks in total at a retention time of 9.610 minutes, 12.225 minutes and 17.705 minutes by gel chromatography, and the peaks respectively correspond to a molecular weight of 670kDa and account for 3.328%; 21.849 is accounted for by molecular weight of more than 670 kDa; and 74.829% with a molecular weight of 6.86 kDa.
In a fourth aspect, the invention provides the cordyceps sinensis polysaccharide extract prepared by the method of the invention or the application of the cordyceps sinensis polysaccharide extract in preparing anti-tumor medicines.
Preferably, the tumor is breast cancer, lymphoma, leukemia, melanoma, colon cancer and lung cancer.
Preferably, the tumors are breast cancer MDA-MB-453, lymphoma Raji, leukemia K-562 and melanoma SK-MEL-28.
The "ratio of the material to the liquid" in the invention refers to the ratio of the amount of the material to the amount of the solvent. The ratio of the material to the liquid in the extraction in the step (1) of the invention is 1:8-1:12(kg/L), which means that the ratio of the cordyceps sinensis to the extraction solvent water is 1:8-1:12(kg/L), i.e. when 1kg of cordyceps sinensis is extracted with water, the volume of the water is 8L-12L. If the water extract is an aqueous water extract solution with a material-to-liquid ratio of 1:3-1:6(g/mL), the water extract solution is obtained by mixing the concentrated water extract without the solvent and the solvent water in a ratio of 1:3-1:6(g/mL), namely, when 1g of the water extract is dissolved into an aqueous solution by using water, the volume of the water is 3mL-18 mL; the sevag reagent is a solution prepared by mixing chloroform and n-butanol according to a volume ratio of 4:1(mL: mL).
The term "about" as used herein means an approximate value or range, e.g., "about 75% by mass" as used herein means that the mass of low molecular weight polysaccharide is about 75% of the total polysaccharide extract mass, i.e., within a range of 75 ± 5%, all falling within the range defined by "about 75%", e.g., 71%, 72%, 73%, 74%, 75%, 76%, 77%/78%. Ranges of 79%, 80% all fall within the range of "about 75%"; preferably, all ranges within 75 ± 3% fall within the range defined by "about 75%". Likewise, "about 25% by mass" means that the mass of the high molecular weight polysaccharide accounts for about 25% of the mass of the total polysaccharide extract, i.e., within a range of 25. + -. 5% both falling within the range defined by "about 75%"; preferably, all ranges within 25 ± 3% fall within the range defined by "about 25%".
The preparation method of the cordyceps sinensis polysaccharide extract is simple and convenient to operate, and the obtained polysaccharide extract has high total sugar content and high activity.
The D113 cation exchange resin is a macroporous weakly acidic acrylic cation exchange resin containing a carboxylic acid functional group (-COOH) in its crosslinked acrylic backbone. The resin is mainly used for industrial water treatment, and can also be used for industrial wastewater treatment, metal recovery, and biochemical medicine separation and purification.
D941 anion exchange resin is macroporous methyl acrylate copolymer cross-linked polymer, and is polyamine alkalescent ion exchange resin obtained through aminolysis of polyethylene polyamine, and is mainly used for refining and decolorizing in food industry such as saccharide, and decolorizing and refining natural medicines such as stevioside, ginsenoside, notoginsenoside, antibiotic, etc.
The D101 resin is a spherical, non-polar polymeric adsorbent. The resin is a crosslinked styrene-divinylbenzene copolymer. The resin has special selectivity for saponin and flavone based on proper pore size and specific surface. The resin is suitable for extracting saponin, flavonoid and some organic substances from aqueous solution.
The AB-8 resin is a spherical polystyrene type weak polar adsorption resin (note: the resin has a certain ester group on the surface and is originally marked as weak polar, but the adsorption mechanism is still hydrophobic and is now determined as nonpolar). The resin is a crosslinked polymer, which is different from the hydrophobic adsorbent of the early stage, and has a weak hydrophilic group attached to the skeleton structure thereof; unlike common ion exchange resins, the ion exchange resins have only non-ionizing functional groups in their structures. The resin has large specific surface area and pore size, is suitable for adsorbing various traditional Chinese medicine components with certain hydrophobicity, and has large adsorption capacity, easy elution and good adsorption kinetics performance. Is stable to heat, organic solvents and acid and alkali under common use conditions, so the service life is longer. It has no adsorption to protein, saccharide, inorganic acid, alkali, salt and small molecule hydrophilic organic matter, so that it can separate Chinese medicine components from these matters. Most suitable for water-soluble and weakly polar substance extraction, separation and purification.
Drawings
FIG. 1 is a gel chromatogram of the obtained Cordyceps sinensis polysaccharide extract DCCSP.
DETAILED DESCRIPTION OF EMBODIMENT (S) OF INVENTION
The following are preferred embodiments of the present invention, and the present invention is not limited to the following preferred embodiments. It should be noted that various changes and modifications based on the inventive concept herein will occur to those skilled in the art and are intended to be included within the scope of the present invention. The reagents used are not indicated by the manufacturer, and are all conventional products commercially available.
Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
In the embodiment of the invention, the dry cordyceps medicinal material is sourced from Yichang Shanchengsheng Shuihu cordyceps limited company.
Examples
1. Reagent and consumable
Table 1:
2. apparatus and device
Table 2:
example 1
Extracting cordyceps sinensis polysaccharide:
(1) alcohol precipitation
Pulverizing 15Kg of dried Cordyceps, extracting with hot water under reflux, and extracting with 120L of water for 2 hr each time for 3 times. Mixing extractive solutions, concentrating, adsorbing with HP-20 macroporous resin, eluting with water, concentrating eluate, and freeze drying to obtain Cordyceps water extract solid.
Placing 300g of the cordyceps sinensis aqueous extract solid in a 5L beaker, adding 1500mL of water, dissolving in a water bath at 60 ℃, and cooling to obtain a cordyceps sinensis aqueous extract solution with a material-to-liquid ratio of 1:5 (g/mL). Subpackaging the cordyceps aqueous extract solution into 2 measuring cups of 5L in equal amount, respectively adding absolute ethyl alcohol with 4 times of volume, sealing by using a preservative film, and carrying out alcohol precipitation at room temperature overnight. Then, centrifuging for 30 minutes at a centrifugal force of 3000g, combining alcohol precipitates, heating in a water bath at 80 ℃ to volatilize ethanol, and obtaining 46.5g of crude polysaccharide precipitated by alcohol.
(2) Sevag deproteinization
Dissolving the alcohol precipitated crude polysaccharide in 1L of water, dissolving in a water bath at 80 ℃, subpackaging the solution in a centrifuge cup, adding Sevag reagent (chloroform: n-butyl alcohol is 4:1, V/V) according to a ratio of 4:1 (sample: Sevag reagent, V/V), oscillating for 30 minutes, centrifuging at 4000rpm for 10 minutes, dividing the solution into three layers after centrifugation, sequentially comprising an organic layer, a protein layer and an aqueous phase layer from bottom to top, taking the aqueous phase layer, and repeating the deproteinizing step for 11 times until no obvious protein layer exists between the aqueous phase and the organic phase. Adding 4 times volume of anhydrous ethanol slowly into the deproteinized aqueous phase layer solution while stirring, precipitating with ethanol at 4 deg.C overnight, and centrifuging at 5000rpm for 10min to obtain deproteinized crude polysaccharide (DPCSP).
(3) Depigmentation
Weighing about 2g of macroporous resin D113, D941, D101 and AB-8 which are pretreated and subjected to suction filtration respectively in a beaker, adding 10mL of polysaccharide solution (obtained by dissolving the deproteinized crude polysaccharide obtained in the step (2) in 600mL of water) respectively, oscillating for 3 hours at 120 times/min, centrifuging, taking 5mL of supernatant into a colorimetric tube, and selecting the macroporous resin with the lightest color of the supernatant after adsorption for subsequent tests. The color depth is D113> D941> D101> AB-8.
Therefore, AB-8 macroporous resin was used in this example. Dissolving the deproteinized crude polysaccharide obtained in the step (2) in 600mL of water, adding the polysaccharide solution onto an AB-8 macroporous resin column (5.0 x 55cm), eluting with water until the eluent is not colored with phenol-sulfuric acid, combining the eluates, concentrating, dialyzing the concentrate with 2k Da dialysis bag pure water to obtain a dialyzed solution in a dialysis bag, and freeze-drying the solution in the dialysis bag to obtain crude destaining polysaccharide (DCCSP) powder. The total sugar content of DCCSP determined by phenol-sulfuric acid method was 87.42%.
Example 2
Crude depigmenting polysaccharide (DCCSP) antitumor test:
(1) cell culture: the leukemia K-562 cells, the breast cancer MDA-MB-453 cells, the lymphoma cancer Raji cells and the colorectal cancer COLO205 cells are placed in a DMEM culture medium, the melanoma SK-MEL-28 cells are placed in an RPMI-1640(Roswell Park medical Institute-1640) culture medium, and then all the cells are placed in a 5% carbon dioxide incubator at 37 ℃ for culture. Cells were observed under an inverted microscope 1 time daily and the medium was changed every 2 days. And carrying out cell passage when the cells in the culture bottle grow to 85-95% of fusion. Discarding the old culture solution, repeatedly washing with PBS for 2 times, adding 2mL of 0.25% pancreatin digestive juice (except HL-60), rounding cells, floating, adding 4mL of culture solution to stop digestion, transferring to a 15mL sterile centrifuge tube, centrifuging for 4 minutes at 1000 r/min, discarding supernatant, and transferring to a new sterile culture bottle at a ratio of 1:4 for culture.
(2) Preparing the medicine: the crude de-pigmented polysaccharide (DCCSP) powder prepared in example 1 was weighed out into the culture medium to prepare 6mg/mL solutions, diluted 3-fold to a series of gradient concentrations with the initial final concentration as the initial final concentration, set up 9 concentration points in total, and then filtered through a 0.22 μm sterile filter to sterilize.
(3) And (3) activity detection: cells in the logarithmic growth phase are collected, counted, resuspended in complete medium, adjusted to the appropriate concentration, and seeded into 96-well plates. At 37 ℃ 5% CO2After incubation under conditions for 24 hours. Crude depigmenting polysaccharide (DCCSP) was added at 100. mu.L/well. Then, the mixture was left at 37 ℃ with 5% CO2Incubate for 72 hours in an incubator. Adding 10% of CCK-8 (fine)Cell counting kit-8), placing the reagent in an incubator at 37 ℃ for incubation for 1-2 hours, detecting the absorbance (A) value of each hole at 450nm of an enzyme-labeling instrument, and respectively calculating the IC50 value (mg/mL) of each drug at 72 hours by data processing software. The results are shown in the following table:
table 3: IC50 value of drug to tumor cell
| Cells | DCCSP(mg/mL) |
| RAJI | 0.1993 |
| K-562 | 0.754 |
| COLO205 | 1.586 |
| MDA-MB-453 | 0.013 |
| SK-MEL-28 | 1.167 |
Example 3
Method for measuring molecular weight distribution of decolored crude polysaccharide (DCCSP)
(1) Solution preparation:
20mM ammonium acetate: ammonium acetate 1.54g is weighed, dissolved by adding 1000mL of water, filtered and degassed by ultrasound.
Series dextran control solutions: appropriate dextran controls of different molecular weights (1, 5, 12, 25, 50, 80, 150, 410, 670kDa) were prepared as 1mg/mL solutions and passed through 0.45 μm membranes.
DCCSP solution: an appropriate amount of DCCSP was taken to prepare a 2mg/mL solution, which was passed through a 0.45 μm membrane.
(2) Gel chromatography analysis: a chromatographic column: TSKgel G5000PWXL (7.8 mm. times.30 cm, 10 μm) and guard column TSKgel guard column PWXL (6.0 mm. times.4 cm); mobile phase: 20mM ammonium acetate, isocratic elution; flow rate: 0.6 mL/min; column temperature: room temperature; sample introduction amount: 20 mu L of the solution; evaporation temperature: 30 ℃; temperature of the drift tube: 30 ℃; carrier gas: air, flow rate 1.60 SLM; gain value: 1.0.
(3) data processing: and (5) carrying out linear regression analysis on the retention time by using the logarithmic value of the molecular weight of the glucan to obtain a molecular weight correction curve. And (4) according to the retention time of each chromatographic peak in the test solution, calculating the corresponding molecular weight by using a correction curve. And calculating the proportion of each component in the analyzed chromatographic peak by an area normalization method.
(4) As a result: performing regression analysis by using the logarithm value of the series of glucan molecular weights as an ordinate and the retention time as an abscissa to obtain a regression equation of-0.4218 x +11.304, R20.9762. As can be seen from FIG. 1, DCCSP consists of three main components, and the molecular weights of peaks 1 and 2 are both greater than 670kDa and the molecular weight of peak 3 is 6.86kDa, as calculated by the regression equation. The ratios of peaks 1, 2 and 3 were 3.328%, 21.849% and 74.829% by normalization.
TABLE 4 polysaccharide DCCSP retention time (min) and molecular weight (Da)
| Peak name | Retention time | Molecular weight | Is in percentage by weight |
| 1 | 9.610 | >670kDa | 3.328 |
| 2 | 12.225 | >670kDa | 21.849 |
| 3 | 17.705 | 6.86kDa | 74.829 |
Claims (11)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910546545.5A CN110256591B (en) | 2019-06-21 | 2019-06-21 | Cordyceps sinensis polysaccharide extract and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910546545.5A CN110256591B (en) | 2019-06-21 | 2019-06-21 | Cordyceps sinensis polysaccharide extract and preparation method and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110256591A CN110256591A (en) | 2019-09-20 |
| CN110256591B true CN110256591B (en) | 2022-02-15 |
Family
ID=67920591
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910546545.5A Active CN110256591B (en) | 2019-06-21 | 2019-06-21 | Cordyceps sinensis polysaccharide extract and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110256591B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116217755B (en) * | 2022-12-07 | 2024-06-14 | 广东省人民医院 | Cordyceps sinensis glycogen content detection method and structure detection method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101307112B (en) * | 2008-07-07 | 2010-12-15 | 中国科学院微生物研究所 | Process for abstracting mycelium polysaccharide by cordyceps fermentation |
| CN101928352B (en) * | 2010-08-13 | 2012-06-06 | 内蒙古昆明卷烟有限责任公司 | Extraction for active ingredients of cordyceps sinensis and application thereof in cigarette filter |
| CN102653567B (en) * | 2012-04-18 | 2014-06-18 | 刘小龙 | Extracting process of cordyceps sinensis mycelium polysaccharide of composite preparation for preventing tumor |
| CN103435712A (en) * | 2013-08-27 | 2013-12-11 | 王辉 | Extraction method of cordyceps sinensis intracellular polysaccharide |
-
2019
- 2019-06-21 CN CN201910546545.5A patent/CN110256591B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN110256591A (en) | 2019-09-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101323646B (en) | A kind of anti-tumor activity polysaccharide Ⅱ and its extraction and separation method | |
| CN114807270B (en) | A kind of burdock root polysaccharide prepared by fermentation of Rhizopus niger and its production process and application | |
| CN107698695B (en) | Homogeneous polysaccharides with immunomodulatory activity and methods of making same | |
| CN110256591B (en) | Cordyceps sinensis polysaccharide extract and preparation method and application thereof | |
| CN101654485B (en) | Spreading hedvotis herb polysaccharide for curing malignant tumor and preparation method thereof | |
| CN104042623A (en) | Application of rhizopus nigricans exopolysaccharides in preparation of medicine for treating or preventing gastrointestinal tumors | |
| CN104829737B (en) | A kind of palmleaf raspberry leaf Thick many candies and preparation method and application | |
| CN113274490A (en) | Preparation method and application of botryococcus longipediculus polysaccharide disease-resistant inducer | |
| CN114133461B (en) | Extraction method and application of gastrodia elata oligosaccharide GEP-2 | |
| CN108467381B (en) | Alhagi sparsifolia extract, method for separating monomeric compounds from alhagi sparsifolia extract and application of monomeric compounds | |
| CN113121718B (en) | Roselle polysaccharide PSGP-2 and preparation method and application thereof | |
| CN106589158B (en) | A kind of screwtree root polysaccharide and preparation method thereof, application | |
| CN110420247B (en) | Polygonum bulbiferum extract and preparation method and application thereof | |
| CN115028753B (en) | Homogeneous polysaccharide of seabuckthorn with anti-tumor effect, separation and purification method and application thereof | |
| CN109331033B (en) | Application of saffron petal total polysaccharide in preparing anti-inflammatory medicine | |
| CN113667027A (en) | Ginseng polysaccharide composition and preparation method and application thereof | |
| CN115260336B (en) | Marine aspergillus versicolor extracellular polysaccharide, preparation method and application thereof | |
| CN111748024A (en) | Preparation method of periplaneta americana polypeptide | |
| CN105294878A (en) | Preparation method of mulberry twig antineoplastic activity polysaccharide RMPW-1 | |
| CN101156865A (en) | New anti-tumor application of cardiac glycosides in Jianxuefenghou | |
| CN110433199B (en) | Traditional Chinese medicine composition with components of tonifying qi, activating blood and detoxifying for treating cerebral ischemia and preparation method thereof | |
| CN110938152B (en) | A kind of polysaccharide RPP1 prepared from fermented shellfish by Bacillus natto and its purification method and application | |
| CN107982276B (en) | The use of chestnut polysaccharide in the preparation of drugs for inhibiting the growth of cancer cells | |
| CN109400743B (en) | A kind of method for extracting galactan sulfate from sea grape | |
| CN111187309A (en) | Preparation technology and application of four components in Cistanche deserticola |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200515 Address after: Room 302, building 32, No. 368, Zhong Zhen'an Road, Chang'an Town, Dongguan City, Guangdong Province Applicant after: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd. Applicant after: YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Address before: Room 601, Building No. 368 Zhenan Middle Road, Chang'an Town, Dongguan City, Guangdong Province, 523867 Applicant before: DONGGUAN DONGYANGGUANG HEALTH PRODUCT RESEARCH AND DEVELOPMENT Co.,Ltd. Applicant before: SUNSHINE LAKE PHARMA Co.,Ltd. |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A polysaccharide extract of Cordyceps sinensis and its preparation method and application Granted publication date: 20220215 Pledgee: Jinhua Branch of Zhejiang Fuzhou Commercial Bank Co.,Ltd. Pledgor: Dongguan dongyangguang Cordyceps research and Development Co.,Ltd.|YICHANG SHANCHENGSHUIDU CORDYCEPS Co.,Ltd. Registration number: Y2025980007727 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |